Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Novartis builds its blockbuster case for Entresto, beating out a cheap ACE inhibitor in a head-to-head study

Source: 
Endpoints
News Tags: 
snippet: 

Novartis execs got the positive data they were looking for from their PIONEER-HF study of Entresto to back accelerating sales of the heart medication.